Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
FOXO4-DRI is also known as Proxofim (research designation), FOXO4 D-Retro-Inverso peptide (full descriptive name), Forkhead box O4 (DRI) (gene-derived name), and FOX04-DRI (alternative spelling)
Heres what the clinical data shows: Most Common: Nausea (affecting 15-44% of users), diarrhea (10-30%), vomiting (7-25%), and constipation (6-24%) Severity: 98.1% of gastrointestinal side effects are mild or moderate, with 99.5% being non-serious Duration: Median duration is 8 days for nausea, 3 days for diarrhea, and 2 days for vomiting Timing: Most side effects occur during initial weeks and dose escalation, declining over time Discontinuation: Only 4.3-10% of users discontinue therapy due to side effects Serious Events: Rare, with no increased risk of pancreatitis or malignancy in clinical trials Management: Slow dose titration, dietary modifications, and hydration significantly reduce symptoms Important Note: Weight loss is NOT caused by side effects
Most users eventually establish a sustainable pattern: perhaps 4-6 weeks of active use followed by 2-3 weeks off, repeated as needed based on sleep quality and life demands
June 19, 2026|Categories: Peptides| Thymosin Alpha-1 can be taken two ways: as a subcutaneous [...] Read More Sublingual GHK-Cu vs Injectable GHK-Cu: Which Is More Effective
US$ 28.75
US$ 29.76
US$ 20.78
US$ 24.40
